Drug search by name

Peginterferon alfa-2a Subcutaneous and Ophthalmological disorders

Result of checking the interaction of drug Peginterferon alfa-2a Subcutaneous and disease Ophthalmological disorders for safety when used together.

Check result:

Peginterferon alfa-2a Subcutaneous <> Ophthalmological disorders

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Decrease or loss of vision, retinopathy including macular edema, retinal artery or vein thrombosis, retinal hemorrhages and cotton wool spots, optic neuritis, papilledema, and serious retinal detachment can be induced or aggravated by alpha interferons. All patients should receive an eye examination at baseline and caution should be exercised in patients with preexisting ophthalmologic disorders. Patients should have periodic ophthalmologic exams during treatment.

Peginterferon alfa-2a Subcutaneous

Generic Name: peginterferon alfa-2a

Brand Name: Pegasys, Pegasys ProClick Autoinjector, Pegasys Prefilled Syringe

Synonyms: Peginterferon alfa-2a, Peginterferon Alfa-2a

What is Peginterferon alfa-2a Subcutaneous?